Clearstead Trust’s Allergan plc AGN Stock Holding History

Clearstead Trust’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-108	Closed	-$21K	–	241
2018 Q3	$21K	Buy	108 +53	+96%	+$9.74K	0.02%	153
2018 Q2	$9K	Buy	+55	New	+$8.83K	0.01%	179

Other funds holding AGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Clearstead Trust's AGN Position: Q4 2018 in Review

Clearstead Trust sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 108 shares — an estimated $21K sold.

Clearstead Trust first reported a position in AGN in Q2 2018 and held it in 2 quarters. The position peaked at $21K in Q3 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

Clearstead Trust reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
Clearstead Trust sold 108 Allergan plc shares in Q4 2018, an estimated $21K.
Clearstead Trust first reported a position in Allergan plc in Q2 2018 and held it in 2 quarters.
Clearstead Trust's Allergan plc position peaked at $21K in Q3 2018.
1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Clearstead Trust's 13F filing for Q4 2018, filed 13 Feb 2019.